5 things to know about CRISPR and gene editing in the COVID era
Here's how precision medicine is evolving in the era of COVID-19. Image: REUTERS/Brendan McDermid
Trevor Martin
Chief Executive Officer and Co-Founder, Mammoth Biosciences
Tooba Durraze
Growth Strategies Lead, Strategic Intelligence, Global Leadership Fellow, World Economic Forum LLC
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Precision Medicine
Have you read?
How is the World Economic Forum bringing data-driven healthcare to life?
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
Subscribe
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
